VR therapy takes on the voices in your head
NCT ID NCT06013748
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests a new virtual reality therapy for people who hear voices that others cannot hear. The therapy uses computer-generated avatars to represent the voices, helping patients learn to cope. Researchers will compare this VR therapy plus usual care to usual care alone in 112 participants with mental illness.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- virtual reality therapy
- What this could lead to
- If it works, this could offer a new, non-drug way to help people who hear distressing voices feel better and gain more control.
- What could go wrong
- This is an early-stage trial with only 112 people, so results may not apply to everyone. The therapy is new and might not work better than usual care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 112 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2022
- Expected to finish
-
Feb 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
16 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Having a DSM-5 diagnosis of a psychiatric disorder * Distressing AVH for minimally 3 months. * Age 16 years or older Exclusion Criteria: * Insufficient command of the Dutch language * Unable to provide informed consent * Primary diagnosis of a substance use disorder, or organic brain disease (such as dementia) * A degree of substance abuse that hinders treatment adherence * Auditory verbal hallucinations in a language not spoken by therapists * Patients cannot receive CBT specifically focused at gaining empowerment over voices during the study period or 6 months prior to enrolment.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hallucinations, verbal auditory are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
3 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
GGZ Drenthe
RECRUITINGAssen, Netherlands
-
Lentis
NOT_YET_RECRUITINGGroningen, Provincie Groningen, Netherlands
-
University Medical Center Groningen
RECRUITINGGroningen, 9712EW, Netherlands